Since ulcerative colitis predominantly affects non-smokers and ex-smokers we have examined the possibility that smoking modifies the humoral immune response to an antigenic challenge from the gut lumen. Gut lavage was used in healthy subjects and patients with ulcerative colitis, including both smokers and non-smokers. Antibodies Cigarette smoking is associated with immunological changes'2 that affect the T cell subsets,3 alveolar macrophages,4 5 reduce natural killer cell function,6 and alter circulating immunoglobulins of the IgG and IgA classes.7-9 Reduced amounts of salivary IgA have been found in heavy smokers, both in normal subjects and patients with epithelial head and neck tumours. "0 Since ulcerative colitis is a disease of nonsmokers" and ex-smokers,'2 smoking may have a protective effect against colitis involving humoral immunity of the gut. '" To examine this possibility, we compared healthy controls, smokers and non-smokers with colitis patients for serum immunoglobulin concentrations and specific antibodies to three gut commensals. Mucosal responses were also examined by measuring in the intestinal secretions total immunoglobulin and specific antibodies to a range of antigens.
I6 lactoglobulin were measured by ELISA to determine specific antibody concentrations of IgG, IgA, and IgM classes. Total IgG, IgA, and IgM were also measured in intestinal secretions and serum. In addition, circulating antibody concentrations of IgG, IgA, and IgM to three gut commensals -E coli (five pooled serotypes) C albicans, and Poroteus mirabilis were measured. There was a significant reduction in the IgA concentration in intestinal fluid of smokers with ulcerative colitis compared with healthy non-smoking controls. No other significant differences were found between the groups. Overall, these data are not consistent with the idea that smoking suppresses immune responses in the gut and suggest that the effect of smoking in colitis is mediated by another mechanism.
Cigarette smoking is associated with immunological changes'2 that affect the T cell subsets,3 alveolar macrophages,4 5 reduce natural killer cell function,6 and alter circulating immunoglobulins of the IgG and IgA classes.7-9 Reduced amounts of salivary IgA have been found in heavy smokers, both in normal subjects and patients with epithelial head and neck tumours. "0 Since ulcerative colitis is a disease of nonsmokers" and ex-smokers,'2 smoking may have a protective effect against colitis involving humoral immunity of the gut. '" To examine this possibility, we compared healthy controls, smokers and non-smokers with colitis patients for serum immunoglobulin concentrations and specific antibodies to three gut commensals. Mucosal responses were also examined by measuring in the intestinal secretions total immunoglobulin and specific antibodies to a range of antigens.
Methods
Two sets of measurements were made. In the first, serum concentrations of total immunoglobulins and specific antibodies to three gut commensals were measured. In the second, concentrations of immunoglobulins and specific antibodies were measured in gut secretions obtained after intestinal lavage.
PATIENTS
Systemic humoral immunity Twenty one healthy male non-smokers, aged 20 to 65 years, and receiving no medication took part in the study on systemic humoral immunity. They were age matched with 21 healthy male smokers (10 or more cigarettes daily for more than one year, mean 15 and range 10-30 per day) and 21 patients with ulcerative colitis; those with colitis were all non-smokers, in remission, and had not taken steroids in the previous six weeks but were currently taking either mesalazine or sulphaslazine. Some 10 ml of venous blood were taken from each subject and sera were stored in 1 ml aliquots at -20°C.
Mucosal humoral immunity Ten healthy non-smokers (two men, mean age 32-2 years) and 12 healthy smokers (five men, mean age 35-2 years) who were receiving no medication took part in the study on mucosal humoral immunity. The mean number of cigarettes consumed was 19 per day (range 3 to 30). In addition 30 patients with colitis in remission and who were not on steroids were included. Nineteen were non-smokers (13 men, mean age 47 9 years) and 11 were smokers (six men, mean age 39 2 years). The mean number of cigarettes consumed daily in this group was 16 (range 2 to 30). Twenty three of the patients with colitis underwent sigmoidoscopy before gut lavage to ensure that the disease was in remission and a rectal biopsy specimen was taken one week later to quantify inflammatory changes (Table I) sheet. Specimens were centrifuged twice and treated with protease inhibitors'" before storage in 1 ml aliquots at -70°C.
MEASUREMENT OF ANTIBODY BY ELISA TECHNIQUES
For Candida albicans and Proteus mirabilis the method was essentially as described previously. 16 Aliquots (200 ,ul) of live bacterial suspension (absorbance=0 34-0 60 nm) in carbonate/ bicarbonate coating buffer (pH 9 6) were added to half the wells of Dynatech (96 wells) microelisa plates with coating buffer (200 ,ul) added to the other half. The plates were centrifuged at 2000 rpm for 15 minutes and incubated overnight at 4°C. The bacteria were then fixed with 200 ,ul of 0-25% glutaraldehyde in isotonic phosphate buffered saline, pH 7-3 with 0 05% Tween 20 (PBST) for 10 minutes at room temperature washed five times with water, treated with 200 p1 of 0 1 M glycine in water for 10 minutes at room temperature, and then washed five times in water. For Escherichia coli, a pool of antigen from five serotypes was used. '7 Test sera were diluted 1/400 in PBST and 100
[Il were added in triplicate to coated and uncoated wells. Lavage fluids were tested either neat or in 1/5 dilution, depending upon the antigen. After incubation for two hours at room temperature, the wells were washed three times in PBST. Some 100 [tl of alkaline phosphatase conjugated anti-human IgG, IgA, or IgM (Sigma or Northeast biomedical) were used at the recommended dilution and incubated for two hours at room temperature, then washed five times in PBST. A total of 100 p1 of alkaline tions were all lower in healthy smokers than in non-smokers, especially IgA, although there is a wide scatter. This was not seen with E coli and C albicans, and was not found when smokers and non-smokers with colitis were compared.
There was no correlation between the number of cigarettes smoked and IgA immunoglobulin concentration for each group.
Discussion
The circulating antibodies measured for each immunoglobulin class -IgG, IgA, and IgM -for three common gut commensals in the three groups of subjects gave 27 sets of data for comparison, but only three significant differences were identified; IgA antibody to P mirabilis was reduced in smokers compared with nonsmokers, while IgG and IgM antibodies to C albicans showed reduced and raised concentrations respectively in patients with colitis. The only significantfinding in our work with intestinal secretions after gut lavage was a reduced concentration of total IgA immunoglobulin in smokers with colitis compared with healthy non-smokers.
The data are probably valid in these groups since the ELISA technique is a sensitive way of measuring total immunoglobulin and antibodies for the different isotypes. Gut lavage as a way of obtaining intestinal secretion is a simple, safe, and non-invasive technique; the solution has the additional advantage of being poorly absorbed with little effect on fluid and electrolyte balance.'920 Protease inhibitors were added to prevent significant proteolysis of immunoglobulin'718 before measurement by ELISA. Five pooled serotypes of E coli were used since intestinal E coli flora are not consistent and often vary between individuals.2' C albicans was used since it is a common gut commensal with limited serotypes and most immunocompetent individuals have responded by producing antibodies. 22 colitis. 
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